AI-generated summary
The authors surveyed 61 adults with delayed sleep phase syndrome 12 to 18 months after a 6-week course of 5 mg oral melatonin taken nightly at 22:00. Of respondents, 96.7% reported the treatment was helpful with almost no side effects, but 91.5% reported a return to their pretreatment sleep pattern within a year.
- Participants
- 61
- Who or what was studied
- 61 adults (37 males, 24 females) diagnosed with delayed sleep phase syndrome at a sleep clinic
- Limits stated in the abstract
- The efficacy outcome relied on subjective self-reports from a survey sent to participants' homes, with no control group described.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.